| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 76.80▼ | 77.14▼ | 77.13▼ | 76.60▼ | 73.93▲ |
| MA10 | 76.82▼ | 77.37▼ | 77.17▼ | 77.30▼ | 72.20▲ |
| MA20 | 76.91▼ | 77.30▼ | 77.60▼ | 75.93▲ | 70.66▲ |
| MA50 | 77.35▼ | 77.49▼ | 77.46▼ | 72.12▲ | 63.08▲ |
| MA100 | 77.35▼ | 77.55▼ | 77.72▼ | 70.85▲ | 63.40▲ |
| MA200 | 77.72▼ | 77.63▼ | 72.62▲ | 64.68▲ | 49.59▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.022▼ | -0.088▼ | -0.086▼ | -0.191▼ | 0.507▲ |
| RSI | 34.200▼ | 39.587▼ | 41.837▼ | 54.640▲ | 58.620▲ |
| STOCH | 37.133 | 22.505 | 39.061 | 31.524 | 57.226 |
| WILL %R | -100.000▼ | -97.541▼ | -97.541▼ | -72.350 | -25.200 |
| CCI | -210.868▼ | -136.463▼ | -106.576▼ | -31.709 | 89.145 |
|
Wednesday, July 22, 2026 01:00 AM
LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/07/26 | 77.17 | 79.38 | 76.385 | 76.405 | 225,804 |
| 23/07/26 | 78.50 | 79.00 | 76.33 | 76.72 | 165,629 |
| 22/07/26 | 77.38 | 79.44 | 77.38 | 77.79 | 208,294 |
| 21/07/26 | 77.26 | 77.90 | 75.81 | 76.57 | 107,251 |
| 20/07/26 | 77.13 | 78.01 | 74.24 | 75.50 | 413,243 |
| 17/07/26 | 76.42 | 78.4999 | 76.25 | 77.67 | 180,923 |
| 16/07/26 | 77.84 | 82.07 | 76.51 | 77.03 | 205,140 |
| 15/07/26 | 78.80 | 79.63 | 77.31 | 78.07 | 159,636 |
| 14/07/26 | 79.08 | 80.43 | 78.23 | 78.74 | 142,189 |
| 13/07/26 | 77.99 | 80.46 | 77.99 | 78.53 | 207,809 |
|
|
||||
|
|
||||
|
|